Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1CNS 1Breast 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13Leukemia, Myeloid, Chronic-Phase 4Philadelphia Chromosome 3Leukemia 3Breast Neoplasms 3Bronchiolitis Obliterans Syndrome 2Translocation, Genetic 1Pathologic Processes 1Neoplasms by Histologic Type 1Neoplasms 1Neoplasm Metastasis 1Leukemia, Myeloid 1Hematologic Diseases 1Glioblastoma 1Bone Marrow Diseases 1Blast Crisis 1Advanced Breast Cancer (Parts 1 and 2) 1

Interventions

bosutinib 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Advanced Breast Cancer (Parts 1 and 2) × bosutinib × Clear all
NCT00959946 2013-02-22

Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer

Pfizer

Phase 1/2 Terminated
32 enrolled 15 charts
BreastCNSGastrointestinal

Advanced Breast Cancer (Parts 1 and 2)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡